These formulations became more accessible during the 2022-2024 FDA-declared shortages of brand-name products, when compounding played a larger role in meeting demand
The enrollment process takes minutes: patient submits health history via secure portal, a clinician reviews eligibility within 24 hours, and if approved, a prescription routes to a licensed 503A compounding pharmacy for preparation and shipment
That means we now have a smaller window of opportunity to maximize or optimize nutritional status. As adding GLP-1 medications to someones routine reduces their overall desire to eat, its critical to focus on nutrient-dense foods in the diet
Pirro, V., Roth, K
Retrieved from: Gaskin, et al., 2024
In 2024 and 2025, an increasing number of cases of ischemic optic neuropathy have been reported through the FDA adverse events reporting system (FAERS) for semaglutide drugs